T-cell-targeted peptide epitope vaccine (Ebola virus infection) (Emergex)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameT-cell-targeted peptide epitope vaccine (Ebola virus infection) (Emergex)
Drug Alias NameT-cell-targeted peptide epitope vaccine (Marburgvirus infection) (Emergex)T-cell-targeted peptide epitope vaccine (microneedle patch/Ebola virus/Marburg virus infection) (Emergex)
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsMarburg Virus DiseaseHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGylden Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGylden Pharma Ltd
Active IndicationsN/A
Inactive IndicationsMarburg Virus DiseaseHemorrhagic Fever, Ebola

Other Information

ATC CodeN/A
Related LinksN/A